Abstract
Uveitis encompasses multiple different conditions that are all characterized by intra-ocular inflammation. Uveitis occurs in the context of many different rheumatological conditions and carries a substantial risk to vision. Uveitis can develop both at the early stages of rheumatic diseases, sometimes even preceding other clinical features, and at later stages of disease. Uveitis can also occur as either a direct or an indirect complication of therapies used to treat patients with rheumatic disease. Conversely, patients with uveitis of non-rheumatic aetiology sometimes require immunosuppression, a treatment option that is not readily accessible to ophthalmologists. Thus, collaborative working between rheumatologists and ophthalmologists is critical for optimal management of patients with uveitis. This Review is written with rheumatologists in mind, to assist in the care of patients with uveitis. We collate and summarize the latest evidence and best practice in the diagnosis, management and prognostication of uveitis, including future trends and research priorities.
Original language | English |
---|---|
Pages (from-to) | 795–808 |
Number of pages | 14 |
Journal | Nature Reviews Rheumatology |
Volume | 20 |
Issue number | 12 |
Early online date | 6 Nov 2024 |
DOIs | |
Publication status | Published - 1 Dec 2024 |
Bibliographical note
Publisher Copyright:© Springer Nature Limited 2024.